/images/2023/09/14/woman_using_laptop.jpg)
/images/2019/12/06/smart_strategies_to_save_money_on_car_insurance.jpg)
:format(webp)/images/2026/01/28/donald-trump-shutterstock.jpg)
/authors/jordan-major-headshot.jpg)
/authors/abasseheadshot.png)
Add Us On Google
Prescription drug costs have long been one of the biggest financial pressures facing retirees hoping for a stress-free retirement. Now, a new announcement from Donald Trump could significantly change what millions of seniors pay for one of the most in-demand medications in the country.
The administration says Medicare will begin covering certain GLP-1 drugs, commonly used for diabetes and weight loss, starting July 1, with out-of-pocket costs dropping to around $50 per month.
Get instant access to hundreds of discounts
Over 50? Join AARP today— because if you’re not a member you could be missing out on huge perks like discounts on travel, dining, and even prescriptions.
Get 25% off membership — just $15 for your first year with auto-renewal — and a free gift if you join today.
Coverage expansion for GLP-1 drugs
The policy targets a class of medications known as GLP-1 drugs, which include widely used treatments like Ozempic, Wegovy, and Zepbound.
These drugs were originally developed to help manage blood sugar in people with Type 2 diabetes, but they have also gained widespread attention for their ability to support weight loss. Demand has surged in recent years, driven by both medical need and growing interest in their broader health benefits.
Under the new plan, Medicare beneficiaries would gain access to these medications at a significantly reduced price, potentially helping users who have struggled with affordability. KFF polling found that 56% of GLP-1 users said the drugs were difficult to afford.
Significant price drop
The cost difference is what's drawing the most attention. "Now think of that, $50 a month. So, it was $2,300, now it's $50 – and the $1,300 doesn't cover a whole month. So it's really even more than that," Trump said when announcing the change.
For seniors currently paying out of pocket, that kind of reduction could translate into thousands of dollars in annual savings. Even for those with partial coverage, lower negotiated pricing could ease monthly expenses and make long-term treatment more manageable.
Growing demand for GLP-1 medications
Interest in GLP-1 medications has exploded across the U.S. A 2025 survey found that roughly 1 in 8 American adults reported using a GLP-1 drug, with strong demand among older Americans.
Many Medicare beneficiaries manage chronic conditions like diabetes, while others are increasingly exploring these drugs for weight-related health concerns. The drugs have become a central part of treatment plans for millions of patients, even as their high price has limited access for others.
Resolve $10,000 or more of your debt
National Debt Relief could help you resolve your credit card debt with an affordable plan that works for you. Just tell them your situation, then find out your debt relief options.1 <p>Clients who complete the program and settle all debts typically save around 45% before fees or 20% including fees over 24–48 months, based on enrolled debts. “Debt-free” applies only to enrolled credit cards, personal loans, and medical bills. Not mortgages, car loans, or other debts. Average program completion time is 24–48 months; not all debts are eligible, and results vary as not all clients complete the program due to factors like insufficient savings. We do not guarantee specific debt reductions or timelines, nor do we assume debt, make payments to creditors, or offer legal, tax, bankruptcy, or credit repair services. Consult a tax professional or attorney as needed. Services are not available in all states. Participation may adversely affect your credit rating or score. Nonpayment of debt may result in increased finance and other charges, collection efforts, or litigation. Read all program materials before enrolling. National Debt Relief’s fees are based on a percentage of enrolled debt. All communications may be recorded or monitored for quality assurance. In certain states, additional disclosures and licensing apply. ©️ 2009–2025 National Debt Relief LLC. National Debt Relief (NMLS #1250950, CA CFL Lic. No. 60DBO-70443) is located at 180 Maiden Lane, 28th Floor, New York, NY 10038. All rights reserved. <b><a href="https://www.nationaldebtrelief.com/licenses/">Click here</a></b> for additional state-specific disclosures and licensing information.</p>
Sign up for a free debt assessment here.
Medicare reach could be exponential
The scale of Medicare means any coverage change carries wide financial implications. More than 66 million Americans rely on Medicare for their health insurance, the majority of them age 65 and older. Expanding access to a high-cost category of drugs within that system has the potential to shift spending patterns both for individuals and the broader health care system.
Lower drug costs could help seniors better manage fixed incomes, particularly at a time when other expenses continue to rise.
Financial ripple effect
The potential savings go beyond just the monthly prescription cost as lower out-of-pocket spending on medications can free up room in a retiree's budget for other essentials.
As an example, someone previously paying hundreds of dollars per month, the shift to a $50 price point could mean reallocating thousands of dollars annually toward housing, food, or savings.
At the same time, broader access to these medications may reduce long-term health care costs if patients are better able to manage chronic conditions.
Policy context for GLP-1 drugs
The administration has already worked to negotiate lower prices for certain medications through a federal program established in 2022, targeting high-cost drugs used by Medicare beneficiaries. Expanding coverage for GLP-1 drugs fits into that larger strategy of making treatments more affordable for seniors.
However, details around implementation still matter. Coverage rules, eligibility requirements, and plan-specific formularies will ultimately determine how widely accessible these medications become.
Potential limits of coverage
Despite the headline savings, not every Medicare beneficiary may see the full benefit immediately. Coverage often depends on specific plan structures, including whether a drug is included on a plan's formulary and what conditions must be met for approval.
Some patients may still face restrictions based on diagnosis, prior authorization requirements, or other criteria. That means actual out-of-pocket costs could vary, even with a broad policy shift in place.
Budget considerations
Expanding coverage for expensive medications raises questions about long-term costs. While lower prices benefit individuals, the overall financial impact on Medicare will depend on how widely the drugs are used and how pricing agreements are structured.
Increased utilization could drive higher total spending, even as per-patient costs decline. Balancing affordability with sustainability will likely remain part of the conversation as the policy takes effect.
Bottom line
Trump's plan to expand Medicare coverage for GLP-1 drugs could significantly reduce costs for millions of seniors, with some paying as little as $50 per month for medications that previously cost far more.
Retirees reviewing money moves for senior benefits could see meaningful savings on a critical medication, making a difference in both their health and their budget. The change has the potential to improve access, ease financial strain, and support better health outcomes. Still, the impact will depend on how coverage is implemented and how widely patients can take advantage of the lower pricing.
More from FinanceBuzz:
- Bills to cut if money feels tight.
- Find out if you could pay less for car insurance in just a few clicks.
- Make these 7 savvy moves when you have $1,000 in the bank.
- 14 moves seniors could benefit from but often forget about.
/images/2021/04/21/adobestock_192812280_1200x628.jpg)
/images/2019/12/06/smart_strategies_to_save_money_on_car_insurance.jpg)
/images/2025/01/28/adobestock_628402894_1.jpeg)
/images/2024/09/04/adobestock_669069249_editorial_use_only_1.jpeg)
/images/2020/03/02/tattoo-woman-bar.jpeg)
/images/2020/12/21/smiling-couple-looking-at-laptop-screen.jpeg)
Intro Offer
Discover will match all the cash back you’ve earned at the end of your first year.
Annual Fee $0 Why we like it
/images/2025/01/23/discover_it_cash_back_card_art_gold.png)
/images/2025/02/04/person_using_card_in_atm.jpg)
/images/2020/06/29/pensive-woman-looking-at-laptop-screen.jpeg)
/images/2023/04/14/fit_woman_having_fun_with_adorable_mongrel_dogs.jpg)
/images/2021/11/15/kids-daycare.jpg)
/images/2026/05/20/older-man-smiling-tree-blue-shirt.jpg)
/images/2024/03/03/woman-with-money.jpg)
/images/2026/05/11/man-60s-pensive-window.jpg)
/images/2025/09/16/portrait-of-senior-man.jpg)
/images/2026/01/07/donald-trump.jpg)
/images/2024/08/21/senior-woman-calculating-budget-at-home.jpeg)
/images/2025/11/12/social-security-graphic.jpg)
